Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial have?
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial has 228 citations in the OpenAlex counts ScholarIQ stores.
When was Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial published?
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial has 2022 year in the ScholarIQ index.
What is the open-access status of Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial?
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial has hybrid oa status in the ScholarIQ index.
What is the DOI of Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial?
The DOI for Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial is on the source record.
What is the PMID of Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial?
The PMID for Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial is on the source record.
What is the OpenAlex record for Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial?
The OpenAlex for Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial is on the source record.